Xencor Company Profile (NASDAQ:XNCR)

About Xencor

Xencor logoXencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. Its segment is related to the development of pharmaceutical products. It uses its XmAb technology platform to create antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions. Its clinical stage product candidates include XmAb5871, which is being developed for autoimmune disease, and XmAb7195, which is being developed for asthma and allergic diseases. Its oncology product candidates are in preclinical stage, which include XmAb14045 and XmAb13676. In addition to its compounds in clinical development, the Company uses its XmAb technology to create antibody compounds which are licensed to other pharmaceutical and biotechnology companies for further development, which include XmAb5574/MOR208 and XmAb13551.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: XNCR
  • CUSIP:
Key Metrics:
  • Previous Close: $24.28
  • 50 Day Moving Average: $24.00
  • 200 Day Moving Average: $23.53
  • 52-Week Range: $10.41 - $29.38
  • Trailing P/E Ratio: 24.88
  • Foreward P/E Ratio: -18.68
  • P/E Growth: 0.00
  • Market Cap: $998.83M
  • Outstanding Shares: 41,138,000
  • Beta: 2.21
Profitability:
  • Net Margins: 39.33%
  • Return on Equity: 22.09%
  • Return on Assets: 15.30%
Debt:
  • Current Ratio: 1.00%
  • Quick Ratio: 1.00%
Additional Links:
Companies Related to Xencor:

Analyst Ratings

Consensus Ratings for Xencor (NASDAQ:XNCR) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.60 (21.91% upside)

Analysts' Ratings History for Xencor (NASDAQ:XNCR)
Show:
DateFirmActionRatingPrice TargetDetails
11/28/2016Canaccord GenuitySet Price TargetBuy$32.00View Rating Details
11/3/2016Leerink SwannReiterated RatingBuy$26.00View Rating Details
10/4/2016Piper Jaffray CompaniesInitiated CoverageOverweight$35.00View Rating Details
9/12/2016WedbushReiterated RatingOutperform$27.00View Rating Details
5/2/2016Oppenheimer Holdings, Inc.Reiterated RatingBuyView Rating Details
12/22/2015FBR & CoReiterated RatingBuy$20.00View Rating Details
8/5/2015MLV & Co.Reiterated RatingBuy$22.00 -> $29.00View Rating Details
5/6/2015Credit Suisse GroupInitiated CoverageOutperform$14.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Xencor (NASDAQ:XNCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
8/2/2016Q216($0.18)$1.13$7.43 million$66.00 millionViewN/AView Earnings Details
5/2/2016Q116($0.27)($0.16)$3.50 million$7.30 millionViewN/AView Earnings Details
3/7/2016Q415($0.30)$0.19$2.50 million$21.80 millionViewN/AView Earnings Details
11/3/2015Q315($0.17)($0.25)$3.57 million$3.50 millionViewN/AView Earnings Details
8/4/2015Q215($0.18)($0.22)$1.90 million$1.01 millionViewN/AView Earnings Details
5/4/2015Q115($0.17)($0.19)$1.80 millionViewListenView Earnings Details
2/19/2015($0.22)($0.04)ViewN/AView Earnings Details
11/10/2014Q3 14($0.19)($0.20)ViewN/AView Earnings Details
7/31/2014($0.19)($0.16)ViewN/AView Earnings Details
5/14/2014Q1 14($0.16)($0.12)$1.71 million$2.20 millionViewN/AView Earnings Details
3/19/2014Q413($0.14)($0.24)$1.71 million$1.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Xencor (NASDAQ:XNCR)
Current Year EPS Consensus Estimate: $0.49 EPS
Next Year EPS Consensus Estimate: $-1.30 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.35)($0.21)($0.26)
Q2 20164($0.36)($0.23)($0.28)
Q3 20163($0.37)$0.06($0.20)
Q4 20163($0.32)$0.06($0.16)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.26)($0.26)($0.26)
Q3 20171($0.28)($0.28)($0.28)
Q4 20171($0.39)($0.39)($0.39)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Xencor (NASDAQ:XNCR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Xencor (NASDAQ:XNCR)
Insider Ownership Percentage: 4.03%
Institutional Ownership Percentage: 64.14%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/6/2016John S Stafford IIIMajor ShareholderSell63,061$27.71$1,747,420.31View SEC Filing  
9/28/2016Edgardo Baracchini JrInsiderSell10,000$25.35$253,500.00View SEC Filing  
9/27/2016John S Stafford IIIMajor ShareholderSell40,000$25.72$1,028,800.00View SEC Filing  
9/2/2016Edgardo Baracchini JrInsiderSell10,000$21.06$210,600.00View SEC Filing  
8/30/2016Bassil I DahiyatInsiderSell40,000$21.80$872,000.00View SEC Filing  
8/26/2016John S Stafford IIIMajor ShareholderSell24,351$21.48$523,059.48View SEC Filing  
8/24/2016John J KuchVPSell25,000$21.95$548,750.00View SEC Filing  
8/23/2016John R DesjarlaisVPSell16,294$21.73$354,068.62View SEC Filing  
8/23/2016John S Stafford IIIMajor ShareholderSell96,828$21.73$2,104,072.44View SEC Filing  
8/16/2016Bassil I DahiyatInsiderSell45,886$22.06$1,012,245.16View SEC Filing  
8/15/2016Bruce L A CarterDirectorSell3,400$22.67$77,078.00View SEC Filing  
8/15/2016John S Stafford IIIMajor ShareholderSell10,000$23.06$230,600.00View SEC Filing  
8/11/2016John S Stafford IIIMajor ShareholderSell30,500$21.87$667,035.00View SEC Filing  
8/10/2016Edgardo Baracchini JrInsiderSell2,500$21.83$54,575.00View SEC Filing  
8/3/2016Edgardo Baracchini, Jr.InsiderSell4,528$20.00$90,560.00View SEC Filing  
8/3/2016John R. DesjarlaisVPSell5,905$20.00$118,100.00View SEC Filing  
7/11/2016Edgardo Baracchini JrInsiderSell1,250$18.13$22,662.50View SEC Filing  
6/28/2016Edgardo Baracchini JrInsiderSell1,250$15.10$18,875.00View SEC Filing  
5/24/2016Bassil I DahiyatCEOSell45,886$13.00$596,518.00View SEC Filing  
4/7/2016Edgardo Baracchini JrInsiderSell3,750$15.00$56,250.00View SEC Filing  
3/17/2016Bassil I DahiyatCEOSell45,886$11.02$505,663.72View SEC Filing  
3/3/2016John R DesjarlaisVPSell14,260$12.01$171,262.60View SEC Filing  
2/1/2016John S Stafford IIIMajor ShareholderSell25$10.79$269.75View SEC Filing  
1/29/2016John S Stafford IIIMajor ShareholderBuy25$10.83$270.75View SEC Filing  
1/4/2016John R. DesjarlaisVPSell1,100$14.13$15,543.00View SEC Filing  
12/17/2015John J KuchVPSell4,781$14.89$71,189.09View SEC Filing  
12/16/2015Paul A. FosterinsiderSell6,025$15.01$90,435.25View SEC Filing  
12/3/2015John S. Stafford IIIDirectorSell30,000$15.13$453,900.00View SEC Filing  
11/25/2015Edgardo Baracchini, Jr.insiderSell2,500$15.00$37,500.00View SEC Filing  
9/3/2015John S Stafford IIIDirectorSell10,000$17.22$172,200.00View SEC Filing  
9/1/2015Edgardo Baracchini, Jr.insiderSell1,250$16.49$20,612.50View SEC Filing  
7/6/2015John S Stafford IIIDirectorSell10,000$22.29$222,900.00View SEC Filing  
7/1/2015Edgardo Baracchini JrInsiderSell2,500$22.24$55,600.00View SEC Filing  
6/16/2015John S Stafford IIIDirectorSell20,000$20.35$407,000.00View SEC Filing  
6/15/2015Bruce L A CarterDirectorSell10,000$19.21$192,100.00View SEC Filing  
6/15/2015Edgardo Baracchini JrInsiderSell1,277$19.85$25,348.45View SEC Filing  
6/12/2015John J KuchVPSell8,756$19.35$169,428.60View SEC Filing  
6/12/2015John S Stafford IIIDirectorSell250,000$19.00$4,750,000.00View SEC Filing  
6/3/2015John S Stafford IIIDirectorSell10,000$18.76$187,600.00View SEC Filing  
6/1/2015Edgardo Baracchini JrInsiderSell1,250$18.14$22,675.00View SEC Filing  
5/26/2015John S Stafford IIIDirectorSell10,000$17.01$170,100.00View SEC Filing  
5/15/2015Edgardo Baracchini JrInsiderSell1,604$15.00$24,060.00View SEC Filing  
8/11/2014John S Stafford IIIDirectorSell124,000$9.37$1,161,880.00View SEC Filing  
12/6/2013John S Stafford IIIDirectorBuy275,000$5.50$1,512,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Xencor (NASDAQ:XNCR)
DateHeadline
News IconXencor Inc XNCR Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:XNCR)
www.bioportfolio.com - February 19 at 8:05 AM
finance.yahoo.com logoIgG4-Related Disease Biomarker Development Update Presented From an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-RD at the 3rd International Symposium on IgG4-Related Diseases & Fibrosis (NASDAQ:XNCR)
finance.yahoo.com - February 18 at 7:41 PM
fool.com logo3 Biotech Stocks to Buy in February (NASDAQ:XNCR)
www.fool.com - February 17 at 5:18 PM
News IconWatching the Numbers on These Shares: Xencor, Inc. (NASDAQ:XNCR) - Midway Monitor (NASDAQ:XNCR)
midwaymonitor.com - February 15 at 7:01 AM
finance.yahoo.com logoXencor to Present at Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:XNCR)
finance.yahoo.com - February 10 at 6:43 AM
News IconXencor Inc XNCR Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250 (NASDAQ:XNCR)
www.bioportfolio.com - January 29 at 6:47 AM
News IconPrice Index Watch on Shares of Xencor, Inc. (NASDAQ:XNCR) - The Tribune (NASDAQ:XNCR)
lakecitytribune.com - January 26 at 6:35 AM
News IconEarnings in Full Force, Analysts Take Aim at Xencor, Inc. (NASDAQ:XNCR) - Wall Street Beacon (NASDAQ:XNCR)
wsbeacon.com - January 26 at 6:35 AM
News IconSphinx Trading Lp Cuts Position in Xencor Inc (XNCR) by $1748899 - Highland Mirror (NASDAQ:XNCR)
www.highlandmirror.com - January 26 at 6:35 AM
News IconShares in View: Xencor Inc. (XNCR) - Sherwood Daily (NASDAQ:XNCR)
sherwooddaily.com - January 21 at 5:52 AM
News IconStock Momentum Skidding to a Halt For Xencor, Inc. (NASDAQ:XNCR) - Wall Street Beacon (NASDAQ:XNCR)
wsbeacon.com - January 18 at 5:56 AM
News IconWill The Needle Move For Xencor, Inc. (NASDAQ:XNCR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:XNCR)
wsbeacon.com - January 18 at 5:56 AM
News IconFocus Equity: Stock Strength Indicator Update on Xencor, Inc. (NASDAQ:XNCR) - Wall Street Beacon (NASDAQ:XNCR)
wsbeacon.com - January 17 at 8:37 AM
nasdaq.com logoCommit To Buy Xencor At $22.50, Earn 15.3% Annualized Using Options - Nasdaq (NASDAQ:XNCR)
www.nasdaq.com - January 13 at 7:18 AM
investornewswire.com logoXencor, Inc. (NASDAQ:XNCR) Strong Sell Recommendations At {RATING_CNT_STRONG_SELLS:378}} - Investor Newswire (NASDAQ:XNCR)
www.investornewswire.com - January 12 at 8:11 AM
capitalcube.com logoXencor, Inc. – Value Analysis (NASDAQ:XNCR) : January 10, 2017 (NASDAQ:XNCR)
www.capitalcube.com - January 10 at 4:25 PM
capitalcube.com logoXencor, Inc. breached its 50 day moving average in a Bullish Manner : XNCR-US : January 9, 2017 (NASDAQ:XNCR)
www.capitalcube.com - January 9 at 3:24 PM
investornewswire.com logoSentiments And Ratings Alert: Xencor, Inc. (NASDAQ:XNCR) - Investor Newswire (NASDAQ:XNCR)
www.investornewswire.com - December 19 at 3:41 PM
News IconStock Watch: FCF Score Check on Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - December 14 at 8:39 AM
News IconCompany Focus: Zooming in on Shares of Xencor, Inc. (NASDAQ:XNCR) - The Business Journal (NASDAQ:XNCR)
belmontbusinessjournal.com - December 11 at 8:06 AM
finance.yahoo.com logoXencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock (NASDAQ:XNCR)
finance.yahoo.com - December 6 at 11:08 PM
News IconXencor, Inc. (XNCR) – Latest Broker Consensus - NewsDen (NASDAQ:XNCR)
newsden.net - December 3 at 7:36 PM
investopedia.com logoXencor's 4.6M-Share Offering Priced at $24 (XNCR) (NASDAQ:XNCR)
www.investopedia.com - December 2 at 8:59 PM
News IconInvestor Hub: Checking on the Numbers for Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - December 2 at 8:53 AM
us.rd.yahoo.com logo8:03 am Xencor prices about a 4.6 mln share underwritten public offering of common stock at $24.00/share for gross proceeds of about $110 mln (NASDAQ:XNCR)
us.rd.yahoo.com - December 1 at 10:15 PM
publicnow.com logoXencor, Inc. Prices Public Offering of Common Stock (NASDAQ:XNCR)
www.publicnow.com - December 1 at 10:15 PM
publicnow.com logoXencor, Inc. Announces Proposed Public Offering of Common Stock (NASDAQ:XNCR)
www.publicnow.com - December 1 at 10:15 PM
marketexclusive.com logoXENCOR,INC. (NASDAQ:XNCR) Files An 8-K Other Events - Market Exclusive (NASDAQ:XNCR)
marketexclusive.com - December 1 at 2:19 AM
News IconLooking at the Numbers for Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - November 30 at 12:55 PM
investornewswire.com logoXencor, Inc. (NASDAQ:XNCR) EPS Estimate At $-0.535 - Investor Newswire (NASDAQ:XNCR)
www.investornewswire.com - November 29 at 1:27 PM
investopedia.com logoBillion-Dollar ‘Biobuck’ Deals Are Mostly Hype (NASDAQ:XNCR)
www.investopedia.com - November 28 at 12:10 PM
News IconWatching the Levels on Shares of Xencor, Inc. (NASDAQ:XNCR) - Wall Street Lion (NASDAQ:XNCR)
wslnews.com - November 25 at 8:13 AM
News IconTechnical Buzz on Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - November 23 at 8:41 PM
News IconKeeping Tabs on Levels for Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - November 21 at 9:01 PM
News IconCompany Focus: Zooming in on Shares of Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - November 21 at 5:50 AM
News IconXencor, Inc. XNCR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:XNCR)
www.bioportfolio.com - November 20 at 11:45 AM
News IconHot Watch to Target- Xencor, Inc.'s (XNCR) | Hot Stocks Point - Hot Stocks Point (NASDAQ:XNCR)
www.hotstockspoint.com - November 19 at 8:16 PM
News IconStock Momentum in Focus on Shares of Xencor Inc. (XNCR) - StockTalk Daily (NASDAQ:XNCR)
stocktalkdaily.com - November 19 at 10:53 AM
News IconVC Score In Focus for Xencor, Inc. (NASDAQ:XNCR) - Marion Business Daily (NASDAQ:XNCR)
marionbusinessdaily.com - November 17 at 8:05 PM
News IconWhat The Charts Are Saying About Xencor, Inc. (NASDAQ:XNCR) - Wall Street Lion (NASDAQ:XNCR)
wslnews.com - November 17 at 1:03 PM
News IconTechnical Investor Update on Shares of Xencor Inc. (XNCR) - StockTalk Daily (NASDAQ:XNCR)
stocktalkdaily.com - November 17 at 1:03 PM
capitalcube.com logoXencor, Inc.: Leads amongst peers with strong fundamentals (NASDAQ:XNCR)
www.capitalcube.com - November 15 at 9:14 PM
finance.yahoo.com logoXencor (XNCR) Looks Good: Stock Adds 13.2% in Session (NASDAQ:XNCR)
finance.yahoo.com - November 15 at 12:14 PM
streetinsider.com logoXencor (XNCR) Announces Prelim. XmAb5871 Phase 2 Data; 82% Initial Response Reported (NASDAQ:XNCR)
www.streetinsider.com - November 14 at 12:45 PM
News IconXencor Presents Preliminary Data from an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-Related Disease (IgG4-RD) a... (NASDAQ:XNCR)
www.advfn.com - November 14 at 12:45 PM
streetinsider.com logoXencor (XNCR) Announces Prelim. XmAb5871 Phase 2 Data; 82% Initial Response Reported - StreetInsider.com (NASDAQ:XNCR)
www.streetinsider.com - November 13 at 11:28 AM
finance.yahoo.com logoXencor Presents Preliminary Data from an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-Related Disease (IgG4-RD) at the American College of Rheumatology 2016 Annual Meeting (NASDAQ:XNCR)
finance.yahoo.com - November 13 at 11:28 AM
finance.yahoo.com logoXencor Presents Preclinical Data on XmAb20717 Dual Checkpoint Blockade and Additional Bispecific Antibody Candidates at Society for Immunotherapy of Cancer (SITC) 2016 Annual Meeting (NASDAQ:XNCR)
finance.yahoo.com - November 11 at 11:42 AM
capitalcube.com logoXencor, Inc. breached its 50 day moving average in a Bullish Manner : XNCR-US : November 11, 2016 (NASDAQ:XNCR)
www.capitalcube.com - November 11 at 11:42 AM
finance.yahoo.com logoXENCOR INC Financials (NASDAQ:XNCR)
finance.yahoo.com - November 9 at 8:41 PM

Social

What is Xencor's stock symbol?

Xencor trades on the NASDAQ under the ticker symbol "XNCR."

Where is Xencor's stock going? Where will Xencor's stock price be in 2017?

5 analysts have issued 12-month target prices for Xencor's stock. Their forecasts range from $26.00 to $35.00. On average, they expect Xencor's stock price to reach $29.60 in the next twelve months.

When will Xencor announce their earnings?

Xencor is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

Who owns Xencor stock?

Xencor's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (9.61%), Deerfield Management Co. (4.91%), Perceptive Advisors LLC (4.34%), State Street Corp (2.05%), Orbimed Advisors LLC (2.04%) and Franklin Resources Inc. (1.57%). Company insiders that own Xencor stock include Bassil I Dahiyat, Bruce L A Carter, Edgardo Baracchini Jr, Edgardo Baracchini, Jr, John J Kuch, John R Desjarlais, John S Stafford III and Paul A Foster.

Who sold Xencor stock? Who is selling Xencor stock?

Xencor's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Deerfield Management Co., Franklin Resources Inc., Oxford Asset Management, Bogle Investment Management L P DE, State Board of Administration of Florida Retirement System and Ladenburg Thalmann Financial Services Inc.. Company insiders that have sold Xencor stock in the last year include Bassil I Dahiyat, Bruce L A Carter, Edgardo Baracchini Jr, Edgardo Baracchini, Jr, John J Kuch, John R Desjarlais and John S Stafford III.

Who bought Xencor stock? Who is buying Xencor stock?

Xencor's stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, EcoR1 Capital LLC, Dimensional Fund Advisors LP, Orbimed Advisors LLC, Russell Investments Group Ltd., State Street Corp, Arrowpoint Asset Management LLC and Cadence Capital Management LLC.

How do I buy Xencor stock?

Shares of Xencor can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Xencor stock cost?

One share of Xencor stock can currently be purchased for approximately $24.28.

Xencor (NASDAQ:XNCR) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Xencor (NASDAQ:XNCR)

Earnings History Chart

Earnings by Quarter for Xencor (NASDAQ:XNCR)

Dividend History Chart

Dividend Payments by Quarter for Xencor (NASDAQ:XNCR)

Last Updated on 2/21/2017 by MarketBeat.com Staff